Zkusit zdarma
Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.

MDGL
Cena:
 
 
Valuace
70
Růst
23
Zdraví
75
preloader

Finanční výsledky Madrigal Pharmaceuticals, Inc. (MDGL)

Měna: USD

Ukazatel20252024202320222021
Diluted EPS-12.85-21.9-19.99-17.23-14.63
Gross Profit902.3M173.9M---
Net Income Attributable to Common Shareholders-288.3M-465.9M-373.6M-295.4M-241.8M
Operating Profit-300.1M-497.9M-380.5M-293.6M-242.5M
Total Revenues958.4M180.1M---